Skip to content

Scancell and Cancer Research UK collaborate to advance novel cancer immunotherapy into clinical trials

Scancell Holdings PLC, a developer of novel immunotherapies for the treatment of cancer, and Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research, are pleased to announce that they have entered into a Clinical Development Partnership to develop Scancell’s ImmunoBody® vaccine, SCIB2, for the treatment of patients with solid tumours, … Continued

Calculus CEO John Glencross featured in the FT Adviser

Calculus Capital CEO John Glencross has been featured in the FT Adviser: Guide to investing in EIS. The guide looked into the drivers behind the increased interest in EIS, how accessible these types of investments are, how to navigate the changes to EIS that came out of the Patient Capital Review and differences between EIS and … Continued

Calculus Capital wins ‘Best Generalist EIS’ at the Tax Efficiency Awards 2017

Calculus Capital is delighted to have won the award for Best Generalist EIS at the Investment Week Tax Efficiency Awards 2017 – presented by the BBC’s Joe Lynam. The judges noted that ‘Calculus Capital embodies the spirit of what EIS is all about’. The Investment Week Tax Efficiency Awards 2017-18, recognise the most successful and forward-thinking … Continued

Cornerstone listed in The Sunday Times Fast Track Ones to Watch 10

Cornerstone has been featured as one of the ‘Ones to Watch 10’ in the 21st annual Sunday Times Virgin Fast Track 100, published in the Business section of the Sunday Times this weekend (3rd December 2017). The Fast Track Ones to Watch 10 represents the best of the rest of the companies who do not quite … Continued

Life after the Budget webinar with CEO John Glencross

Following the budget last week, John Glencross, CEO of Calculus Capital hosted a webinar discussing the outcome, specifically the effect on EIS and VCT investing. If you would like to view a replay of the session in full, please click here. [youtube id=”KCAI8p61cDU”] As a reminder, both the Calculus EIS and VCT funds are now … Continued

Once Upon A Time acquires Toucan

Calculus portfolio company, Once Upon A Time, has acquired the brand activation and shopper marketing agency Toucan. This is Once Upon a Time’s fifth acquisition, and further supports their strategy to offer independent and fully integrated solutions for clients, this includes media, advertising, digital, shopper marketing and production. Once Upon A Time chief executive Joe … Continued